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During inflammation, the inflammasomes representing a group of multi-protein complexes trigger the biological
maturation of pro-inflammatory cytokines such as interleukin-1β and interleukin-18 by proteolytic activation of
caspase-1 from its inactive proforms. The individual genes encoding components of the inflammasome machinery
are regulated at transcriptional and post-transcriptional levels. Once activated, they drive a wide variety of cellular
responses that are necessary to mediate host defense against microbial pathogens and to guarantee tissue
homeostasis. In the present work, we have studied the expression of the different inflammasomes in various
primary hepatic cell subpopulations, in models of acute inflammation and during experimental liver fibrogenesis.
We demonstrate that NLRP-1, NLRP-3 and AIM2 are prominently expressed in Kupffer cells and liver sinusoidal
endothelial cells, moderately expressed in periportal myofibroblasts and hepatic stellate cells, and virtually absent in
primary cultured hepatocytes. We found that the challenge with the lipopolysaccharides results in a time- and
concentration-dependent expression of the NOD-like receptor family members NLRP-1, NLRP-3 and NLRC4/NALP4
in cultured hepatic stellate cells and a strong transcriptional activation of NLRP-3 in hepatocytes. Moreover, we
detect a diverse regulatory network of the different inflammasomes in the chosen experimental models of acute
and chronic liver insult suggesting that the various inflammasomes might contribute simultaneously to the
outcome of inflammatory and fibrotic liver insult, irrespectively of the underlying inflammatory stimulus.
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The inflammasomes are cytoplasmic multiprotein com-
plexes that have recently been identified in immune
cells as an important sensor of signals released by cellu-
lar injury and death. During inflammation they trigger
the maturation of pro-inflammatory cytokines such as
interleukin-1β (IL-1β) and engage innate immune defenses
and function as a guardian of organ homeostasis [1-5].
Likewise, cellular stress, viral or bacterial infection, free
cytoplasmic DNA, or any other kind of injury leads to
activation of specialized receptors resulting in the forma-
tion of these high-molecular-mass inflammasome plat-
forms [6-9]. The assembly of these molecular platforms
is unique, triggered by a variety of endogenous and* Correspondence: rweiskirchen@ukaachen.de
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reproduction in any medium, provided the orexogenous signals and follows a defined chronological
sequence: after recognition of pathogen-derived mole-
cules, the inflammasomes induce the autocatalytic gen-
eration of intracellular active caspase-1 (CASP-1) that in
turn induces the proteolytic cleavage and biological acti-
vation of the IL-1β- and IL-18-precursors [6,7,10]. In
principal, there are four individual inflammasomes (i.e.
NLRP-1, NLRP-3, NLRC4/NALP4, and AIM2) that are
each composed of a sensor molecule that is a member of
the family of nucleotide-binding oligomerization domain
(NOD)-like receptors (NLR) [11]. In its activated form,
this sensor molecule has the ability to physically interact
with CASP-1 or to recruit this protease via an inter-
mediary adaptor molecule termed apoptosis-associated
speck-like protein or caspase recruitment domain
(CARD) of the adaptor protein ASC [4]. Once activated,
a complex network of cellular reactions is triggered lead-
ing to local and systemic (e.g. acute-phase response)td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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platelets as well as activation of the innate immune
system [7]. Furthermore, the activation of the inflam-
masomes is linked to host defense against microbial
pathogens, in many other multifaceted diseases such as
metabolic syndrome and inflammatory bowel disease. In
addition, inflammasomes are relevant in the regulation of
diverse important aspects of inflammation and tissue re-
pair such as pyroptosis representing a specialized form of
cell death [5]. Based on these eminent functions, it is not
surprising that mutations within this family of genes are
associated with severe immune diseases and supposed to
be involved in tumorigenesis [12]. Most studies high-
lighting the regulation and function of the different
inflammasome branches are presently available from
lung but it is now well documented that inflammasome
activation is a general phenomenon found in all organs
that is also proposed to be involved in insulin signaling,
β-cell function and formation of atherosclerosis [5,13].
In regard to liver it has been recently demonstrated
that the NLR family members NLRP6/NALP6 and
NLRP-3 in conjunction with IL-18 negatively regulate
progression of non-alcoholic fatty liver disease [14] and
that the application of endotoxins including lipopolysac-
charide (LPS) or fatty acids results in increased IL-1β
production and strong activation of the NLRP-3 inflam-
masome [15,16]. Moreover, it was proposed that the in-
duction and proteolytical activation of CASP-1 during
activation of inflammasomes has hepatoprotective effect,
in part through regulation of cell death pathways after
major trauma [17]. In line, the silencing of NLRP-3 dur-
ing liver ischemia-reperfusion by small hairpin RNAs
confirmed that NLRP-3 signaling is involved in progres-
sion of liver injury and that its lack can protect the liver
by reducing the concentration of IL-1β, IL-18, TNF-α,
and IL-6 through downregulation of CASP-1 activation
and NF-κB activity in mice [18]. At the cellular level, it
was proposed that the activation of inflammasome com-
ponents regulate a variety of endogenous functions in
hepatic stellate cells (HSC) and are required for the
development of liver fibrosis [19]. However, precise ac-
tivities and involved signaling pathways of individual
inflammasomes in liver cells are still enigmatic and the
exact determination how the inflammasomes are acti-
vated in different diseases and experimental settings
remains a demanding challenge.
Here we studied the inflammasome expression in
various primary hepatic cell subpopulations and in ex-
perimental models of acute and chronic inflammation
and ongoing hepatic fibrogenesis. We demonstrate that
NLRP-1, NLRP-3 and AIM2 are prominently expressed
in Kupffer cells (KC) and liver sinusoidal endothelial
cells (LSEC), moderately expressed in periportal myofi-
broblasts (pMF) and HSC, and virtually absent in primarycultured hepatocytes. We further demonstrate that
in vitro stimulation with LPS results in a time- and
concentration-dependent activation of NLRP-1, NLRP-3
and NLRP4 in cultured HSC and a strong activation
of NLRP-3 in hepatocytes. In summary, we found a
dynamic transcriptional regulation of the diverse inflam-
masomes in experimental models of acute and chronic
liver insult suggesting that the various inflammasomes
might contribute alone or in conjunction with each other
to the outcome of liver insult.
Methods
Cell culture
Primary HSC, KC and LSEC were isolated from male
Sprague–Dawley rats by a standard Nycodenz den-
sity gradient centrifugation technique and cultured as
described previously [20,21]. Fully transdifferentiated
myofibroblasts (MFB) were obtained by subcultivation of
HSC seven days after initial plating. Primary hepatocytes
were isolated after the collagenase method established
by Seglen [22] and plated and cultured for one day on
collagen-coated dishes in HepatoZYME-SFM medium
(Gibco, St Louis, MO, USA). pMF were prepared fol-
lowing established protocols [23], characterized by their
microscopic appearance, their positivity for fibulin-2 and
cultured essentially as described previously [24]. The rat
cirrhotic fat storing cell line CFSC-2G [25,26] was cul-
tured in Dulbecco’s modified Eagle medium (DMEM)
containing 10% fetal calf serum (FCS) (Gibco), 4 mM
L-Glutamine, 100 IU/ml penicillin, 100 μg/ml strepto-
mycin, and 1 x non essential amino acids (all from
Cambrex, Verviers, Belgium).
LPS stimulation
For endotoxin stimulation, CFSC-2G were starved for
16 hr in DMEM containing 0.5% FCS (Gibco) and
stimulation was done with indicated LPS concentrations
in medium containing 0.2% FCS. When primary hepato-
cytes were stimulated with LPS, the cells were initially
plated in HepatoZYME, then cultured in DMEM (10%
FCS) overnight, followed by starvation for 8 h in DMEM
(0.5% FCS), and stimulated with LPS as described above.
RNA isolation and qRT-PCR
RNA from primary liver cells, rat cirrhotic fat storing
cell line CFSC-2G or total liver tissue was isolated by
the guanidine thiocyanate/CsCl method, followed by
DNAse digestion using the Purelink RNA Mini kit
system (Invitrogen, Life Technologies, Darmstadt,
Germany). Total RNA was quantified and 2 μg samples
reverse transcribed using Superscript II reverse tran-
scriptase and random hexamer primers (both from
Invitrogen). For the individual TaqMan PCR assays, the
cDNA derived from 25 ng RNA was amplified in 25-μl
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Germany) and primer combinations given in Table 1.
The amplification of all respective target gene sequences
were done as follows: melting at 95°C for 10 min and
then 40 cycles at 95°C for 15 sec and 60°C for 1 min,
respectively. Normalization was done either to theex-
pression of GAPDH or rS6 mRNAs.
SDS-PAGE and immunoblotting
Whole-cell and liver protein extracts were prepared
essentially as previously described [27]. Equal amounts
of proteins (20 μg/lane) were resolved in NuPAGETM
Bis-Tris gels (Invitrogen) and electroblotted on a Protran
membrane (Schleicher & Schuell, Dassel, Germany).
The sources and concentrations of antibodies used in
Western blot analysis are given in Table 2.
Experimental in vivo liver injury models
(i) Bile duct ligation (BDL) in rats: Male Sprague Dawley
rats were subjected to bile duct ligation for 2, 7 or
14 days following a protocol previously described [28,29].
Sham operated rats that were sacrificed at the same time
points served as controls. (ii) CCl4 application in rats: A
total of 30 male Sprague Dawley rats at age six to eight
weeks and weighing about 180–200 g were utilized for
this study. The rats received intraperitoneal injections
twice weekly of 1 ml/kg of CCl4 in an equal volume of
mineral oil for up to 12 weeks, whereas mineral oil alone
was used for 12 control animals following established
protocols. Liver specimens were harvested and snap fro-
zen and stored at −80°C for protein and RNA isolation.
(iii) LPS and Concanavalin A (Con A) models in mice:
Eight weeks old C57BL/6 wild type mice were subjected
to a single intravenous injection of 20 mg/kg body
weight Con A (Sigma) as previously described [30] or
LPS (2.5 μg/g body weight). After 8 hrs (Con A) or after
2 or 6 hrs (LPS), mice were sacrificed and liver extracts
prepared for qRT-PCR and Western blot analysis. All
animal experiments performed were approved by the
local review board according to prevailing guidelines for
scientific animal experimentation.
Immunohistochemistry of liver sections
Liver tissue sections were deparaffinized and rehydrated
with xylene and decreasing graded ethanol, and antigen
retrieval was engendered by heating the sections in
0.01 M sodium citrate buffer (pH 6) in a microwave
for 20 min. Blocking of nonspecific binding sides and
antigen detection was essentially done as described
elsewhere [31]. The source of the NLRP-3, AIM2, and the
NALP4/NLRP4 antibodies used for this analysis are given
in Table 2. Stains with normal rabbit control serum served
as negative controls. The specimens were briefly counter-
stained with hematoxylin and representative images madeat a magnification of x200 using a Nikon Eclipse 80i
microscope (Nikon, Düsseldorf, Gemany) equipped with
the NIS Elements Vis software (version 3.22.01).
Terminal transferase dUTP nick end-labelling assay
(TUNEL)
For DNA fragmentation detection resulting from apop-
totic signalling cascades, we used In Situ Cell Death
Detection Kit Fluorescein (# 1684795, Roche Diagnostics,
Mannheim, Germany) according to manufacturer’s
instructions. The presence of nicks in the DNA of
cultured cells was identified by terminal deoxynucleotidyl
transferase (TdT), an enzyme that catalyzes the addition
of labelling dUTPs. In brief, cells were seeded on glass
slides and incubated with 200 ng/ml LPS for 30 min or
16 hrs. Thereafter, slides were rinsed with PBS, cells
permeabilized in 0.1% Trition, 0.1% sodium citrate for 3
min on ice, and TUNEL reaction mixture added. As a
negative control, the cells were only incubated with label
solution and as a positive control, the cells were
incubated after permeabilization with DNAse I Mix for
10 min. Cells were analyzed by fluorescence microscopy for
direct fluorescein in a Leica DMLB microscope (Leica,
Wetzlar, Germany) using the DISKUS software (version
4.50.1638) obtained from Carl H. Hilgers (Königswinter,
Germany).
LDH assay
The measurement of cell death was done in 96 well plate
formats using the Cytotoxicity detection kit+ (LDH),
version 5 (Roche) that allows detection of cell-mediated
cytotoxicity and quantification of the cytotoxic potential
of compounds. The assay was done essentially as out-
lined in the manufacturer’s instruction. Briefly, 100 μl of
cell-free culture supernatants obtained from equal cell
numbers (seeded at a density of 2.5 x 105 cells/well in
6 well-plates) that were incubated with different concen-
tration of LPS were incubated with 100 μl of the reaction
mixture from the test system kit. After incubation for
25 min at room temperature, 50 μl stop solution was
added, the plates were shacked for 10 min and the for-
mation of formazan was measured in a Wallac 1420
Victor Multilabel Counter (Wallac Oy, Turku, Finland)
equipped with a 490 nm filter and the WIACALC
(version 1) software. For standardization of LDH activity,
purified LDH from hog muscle (Roche, #101107085001,
Lot no. 12169925) with a specific activity of 597 U/mg
was included in this analysis.
Measurement of influx of neutrophils, monocytes and
other immune cells in livers of mice subjected to BDL
or CCl4 treatment via flow cytometry
To determine the influx of leukocytes into the livers of
animals that received BDL surgery or were injected with
Table 1 Primers used for quantitative TaqMan analysis
Rat
Gene of
interest
GenBank no. Primers
NLRP-1 NM_001145755 For: 5’-gccctggagacaaagaatcc-3’
Rev: 5’-agtgggcatcgtcatgtgt-3’
NLRP-3 NM_001191642 For: 5’-gctgtgtgaggcactccag-3’
Rev: 5’-gaaacagcattgatgggtca-3’
NLRC-4 NM_001106707 For: 5’-ggccggaagtgaagctcta-3’
Rev: 5’-cccctccagttgcttcag-3’
AIM-2 XM_222949 For: 5’-tggaaaccagagcaaaacaa-3’
Rev: 5’-tgggctttgcagccttaata-3’
IL-1β NM_031512 For: 5’-tgtgatgaaagacggcacac-3’
Rev: 5’-cttcttctttgggtattgtttgg-3’
IL-18 NM_019165 For: 5’-cctgatatcgaccgaacagc-3’
Rev: 5’-ccttccatccttcacagatagg-3’
ASC NM_172322 For: 5’-gctcacaatgtctgtgcttagag-3’
Rev: 5’-gcagtagccacagctccag-3’
TNF-α NM_012675 For: 5’-gcccagaccctcacactc-3’
Rev: 5’-ccactccagctgctcctct-3’
rS6 NM_017160 For: 5’-tgctcttggtgaagagtgga-3’
Rev: 5’-caagaatgccccttactcaaa-3’
Mouse
Gene of
interest
GenBank no. Primers
NLRP-1a NM_001004142 For: 5’-attttgtggccctccaaga-3’
Rev: 5’-ttgaaagtgggcaacatgg-3’
NLRP-1* NM_001004142 For: 5’-tggcacatcctagggaaatc-3’
Rev: 5’-tcctcacgtgacagcagaac-3’
NLRP-3 NM_145827 For: 5’-cccttggagacacaggactc-3’
Rev: 5’-gaggctgcagttgtctaattcc-3’
NLRC-4 NM_001033367 For: 5’-tgatctccaagagatgaagttgg-3’
Rev: 5’-gatcaaattgtgaagattctgtgc-3’
AIM-2 NM_001013779 For: 5’-tcaggaagttttcctttttctca-3’
Rev: 5’-acagtcccaggatcagccta-3’
IL-1β NM_008361 For: 5’-tgtaatgaaagacggcacacc-3’
Rev: 5’-tcttctttgggtattgcttgg-3’
IL-18 NM_008360 For: 5’-caaaccttccaaatcacttcct-3’
Rev: 5’-tccttgaagttgacgcaaga-3’
ASC NM_023258 For: 5’-gagcagctgcaaacgactaa-3’
Rev: 5’-gtccacaaagtgtcctgttctg-3’
TNF-α NM_013693 For: 5’-tcttctcattcctgcttgtgg-3’
Rev: 5’-ggtctgggccatagaactga-3’
IL-6 NM_031168 For: 5’-gctaccaaactggatataatcagga-3’
Rev: 5’-ccaggtagctatggtactccagaa-3’
IL-10 NM_010548 For: 5’-ggctgaggcgctgtcatcg-3’
Rev: 5’-tcattcatggccttgtagacacc-3’
Table 1 Primers used for quantitative TaqMan analysis
(Continued)
IFN-γ NM_008337 For: 5’-ggaggaactggcaaaaggatgg-3’
Rev: 5’-tgttgctgatggcctgattgtc-3’
CCL-2 NM_011333 For: gtgttggctcagccagatgc-3’
Rev: gacacctgctgctggtgatcc-3’
GAPDH XM_001473623 For: 5’-actgccacccagaagactg-3’
Rev: 5’-caccaccctgttgctgtag-3’
rS6 BC092050 For: 5’-cccatgaagcaaggtgttct-3’
Rev: 5’-acaatgcatccacgaacaga-3’
Note: * The primer combination for was taken from Ganz et al., WJG
2001;21:4772–8. It was taken to amplify NLRP-1 in hepatocytes. The NLRP-1a
primer combinations were taken when NLRP-1 was amplified from total liver
extracts.
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lyzed by Fluorescence activated cell sorting (FACS). In-
dividual leukocyte subsets were identified by their
positivity for CD45 (all leukocytes), CD11b (monocytes
and granulocytes), CD11b F4/80 (macrophages), and Ly-
6G (neutrophils). A FACS Canto-II (BD Biosciences,
Heidelberg, Germany) was used for flow cytometric
analysis. The acquired data sets were analyzed by
FlowJo software (TreeStar, Ashland, OR) and individual
cell subsets depicted in percentage of all cells measured.
The analysis shown was done from livers of animals
taken 5 days after BDL surgery and 48 h after single
CCl4 injection.Statistical analysis
Statistical analyses was performed using the t-test for
comparison of groups and the Kruskal-Wallis test for
nonparametric multiple comparison with a statistical
software program (STATGRAPHICS Plus, version 5.1).
When appreciable, results are depicted with their me-
dian values. Probability values of less than 0.05 or 0.01
were considered as statistically significant. To establish
the differences within individual groups, we used the
Mann–Whitney test. Individual p-values for each experi-
ment are given in Additional file 1.Results
Establishment of quantitative real time PCR (qRT-PCR)
assays for analysis of inflammasomme expression in
mouse and rat
There are several key regulatory genes involved in the
initiation and regulation of inflammatory pathways. To
allow relative mRNA quantification of the different
components in mice and rats, we have established
methodologies for measurement of NLRP-3, NRLC4,
AIM2, IL-1β, IL-18, ASC, TNF-α, and rS6 in rat (Additional
file 2: Figure S1) and NLRP-1b, NLRP-1c, NLRP-3, NLRC4/
NALP4, AIM2, IL-1β, IL-18, ASC, TNF-α, IL-6, IL-10,
Table 2 Antibodies used in this study
Primary antibodies
Protein/Antibody Clonality* Supplied by Epitope, location Dilution
STAT1 (sc-346) Poly Santa Cruz Biotechnology,
Santa Cruz, CA, USA
raised peptide mapping near the C-terminus of
STAT1 p84/p91 of human origin
1 : 500
pSTAT1 (#9167) Mono (r) Cell Signaling, Technology,
Danvers, MA, USA
phospho-STAT1 (Tyr701) (58D6), raised against synthetic
phosphopeptide corresponding to residues
surrounding Tyr701 of human STAT1
1 : 1,000
STAT3 (#4904) Mono Cell Signaling raised a STAT3 fusion protein corresponding to the
carboxy-terminal sequence of mouse Stat3 protein
1 : 1,000
pSTAT3 (#9134) Poly Cell Signaling phospho-STAT3 (Ser727), raised against a synthetic
phosphopeptide corresponding to residues
surrounding Ser727 of mouse Stat3
1 : 1,000
NFκB (sc-8008) Mono Santa Cruz NFκB, raised against amino acids 1–286 of NFκB p65
of human origin
1 : 1,000
pNFκB (#3033) Mono Cell Signaling phospho NFκB; raised against a synthetic
phosphopeptide corresponding to residues
surrounding Ser536 of human NF-κB p65
1 : 1,000
JNK (#9252) Poly Cell Signaling SAPK/JNK, raised against a GST/human JNK2 fusion
protein
1 : 1,000
pJNK (#9251) Poly Cell Signaling phospho-SAPK/JNK (Thr183/Tyr185), raised against a
synthetic phosphopeptide corresponding to residues
surrounding Thr183/Tyr185 of human SAPK/JNK
1 : 1,000
pJNK (#4668) Mono (r) Cell Signaling phospho-SAPK/JNK (Thr183/Tyr185) (81E11), raised
again a synthetic phosphopeptide (KLH-coupled)
corresponding to residues surrounding Thr183/Tyr185
of human SAPK/JNK.
1 : 1,000
Casp-3 (#9664) Mono (r) Cell Signaling cleaved Caspase-3 (Asp175) (5A1E), raised against a
synthetic peptide corresponding to amino-terminal
residues adjacent to Asp175 of human caspase-3
1 : 1,000
LCN2 (AF3508) Poly R&D Systems, Wiesbaden,
Germany
recombinant rat Lipocalin-2/NGAL produced in mouse
myeloma cell line NSO, polyclonal goat IgG
1 : 1,000
AIM-2 (14-6008-93) Poly eBioscience, San Diego,
CA, USA
rabbit antibody that reacts with human, mouse, and
rat AIM-2
1 : 1,000
NALP1 (4990) Poly Cell Signaling human NALP1, raised against a synthetic peptide that
corresponds to a region surrounding Gly1081 of human
NALP1, crossreacts with human, mouse and rat NALP1
1 : 1,000
NALP3 (sc-66846) Poly Santa Cruz Cryopyrin/NALP3 (H-66), rabbit antibody raised against
amino acids 25–90 mapping near the N-terminus of
human Cryopyrin
1 : 1,500
NALP4/NLRP4 (ab 47241) Poly Abcam, Cambridge, UK raised against synthetic peptide corresponding to
amino acids 139–157 of human NALP4
1 : 1,000
β-actin (#A5441) Mono Sigma-Aldrich, Taufkirchen,
Germany
β-actin, synthetic peptide N-terminus (clone AC-15) 1 : 10,000
GAPDH (sc-32233) Mono Santa Cruz GAPDH (clone 6C5) 1 : 1,000
Secondary antibodies
sc-2004 NA Santa Cruz goat anti-rabbit IgG-HRP 1 : 5,000
sc-2056 NA Santa Cruz donkey anti-goat IgG-HRP 1 : 5,000
sc-2005 NA Santa Cruz goat anti-mouse IgG-HRP 1 : 5,000
* Abbreviations used for clonality are: Mono, monoclonal antibody produced in mouse; Mono (r), monoclonal antibody produced in rat; NA, not applicable; Poly,
polyclonal antibody produced in rabbit.
Boaru et al. Journal of Inflammation 2012, 9:49 Page 5 of 16
http://www.journal-inflammation.com/content/9/1/49IFN-γ, and GAPDH in mice (Additional file 3: Figure S2).
In addition, we have established a protocol for measuring
CCL2/MCP-1 mRNA expression in both species (not
shown). These assays are designed for quantitative analysis
or mRNA expression using the TaqMan platform. Thedifferent primer combinations (Table 1) that are used
for amplification are designed in a fashion that allows
amplification of respective target gene sequences
under same cycling conditions (melting temperature:
95°C and amplification/extension temperature 60°C)
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respective components.
Expression of NLR family members in primary hepatic cell
subpopulations
To get a first hint of inflammasome expression in the
different hepatic cell subpopulations, we isolated KC,
LSEC, pMF, HSC/MFB, and hepatocytes and quantified
the relative expression of NLRP-1, NLRP-3, and the
interferon-inducible HIN200 family member AIM2 in
these cell entities. This analysis revealed that all three
genes are highest expressed in KC and LSEC, while the
expression was only weak in cultured pMF and HSC/
MFB (Figure 1).
Transcriptional regulation of inflammasome related genes
in CFSC-2G after LPS challenge
It is well established that the endotoxin LPS plays an
important modulator role in acute liver injury as well
as chronic liver diseases. In addition, it was recently
demonstrated that components of the inflammasome are
expressed in immortalized and primary HSC and that the
lack of ASC and NLRP-3 interfere with the process of
ongoing fibrogenesis after CCl4 or thioacetamide (TAA)
challenge that become apparent in reduced collagen de-
position and HSC activation in mice lacking ASC or
NLRP-3 [19]. To analyze the expression of relevant
inflammasomes after inflammatory stimuli in more de-
tail, we challenged cultured CFSC-2G cells with different
concentrations of LPS (50, 100, and 200 ng/ml) and mea-
sured the mRNA expression of NLRP-1, NLRP-3, NLRC-
4, AIM2, IL-1β, IL-18, ASC, and TNF-α after 30 min, 1
h, 2 hrs, 4 hrs, 8 hrs, and 16 hrs (Figure 2). As expected,
the analysis shows a rapid increase in TNF-α expression0
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Figure 1 Expression of NLRP-1, NLRP-3 and AIM2 in primary
hepatic cells. Total RNA from Kupffer cells (KC) cultured for 2 days,
freshly isolated sinusoidal endothelial cells (LSEC), portal fibroblasts
(pF) in primary culture, hepatic stellate cells (HSC/MFB) cultured for
4 days and hepatocytes (PC) cultured for 2 days were isolated and
subjected to quantitative real time PCR for NLRP-1, NLRP-3, and
AIM2. In this analysis, the expression of the different genes was set
to 100% in KC. The individual primers used for quantitative analysis
are depicted in Table 1. For detailed statistical analysis of this set of
experiments see Additional file 1.that was highest after 1 h and strongly dependent on the
concentration of LPS. In addition, we noticed a simul-
taneous upregulation of IL-1β expression. The expres-
sion of all four inflammasomes was not altered after
30 min of LPS challenge (Figure 2A).
However, one hour after LPS stimulation, the expres-
sion of NLRP-3 was dose-dependently upregulated, while
all other genes were not affected at that time point. Inter-
estingly, two hours after LPS stimulation the expression
of NLRP-1, NLRP-3, NLRC4/NALP4 were significant
upregulated to a similar degree, while the expression of
AIM2 was lowered in cells that received LPS (Figure 2C).
The highest expression of these components at that
time point was observed in cells that were triggered
with 100 ng LPS/ml culture medium, while even higher
concentrations did not significantly affect the expression
of these genes. At later time points, we only noticed a
sustained higher expression of NLRC4/NALP4 and IL-1β
(Figure 2F) suggesting that the different inflammasomes
and genes that trigger inflammasome activity have a well
defined individual expression kinetic after stimulation
with LPS.
To rule out that LPS induced cytotoxic effects in
CFSC-2G cells under the chosen experimental condi-
tions that might interfere with the expression of the
individual inflammasome genes, we further measured cell
death and cell lysis by use of TUNEL assay (Additional
file 4: Figure S3) and a cytotoxicity detection assay that is
based on measurement of lactate-dehydrogenase (LDH)
activity released from the cytosol of damaged cells
(Additional file 5: Figure S4). Both assays revealed that
the incubation of the cells with LPS does not result in
plasma-membrane damage or activation of endonu-
cleases that would be indicative for cells that undergo
apoptosis.
mRNA expression of inflammasomes during experimental
liver insult induced by ligation of the common bile duct
To analyze the expression of inflammasome genes during
the process of acute and chronic liver insult, we first
monitored expression of relevant genes in rats that
underwent bile duct ligation (BDL). This model repre-
sents a well established experimental model of cholestatic
liver disease. We performed qRT-PCR using RNA that
was isolated from rats after 2, 7 or 14 after BDL surgery
and compared the expression of the different genes to
those observed in livers of sham-operated control rats.
This analysis revealed that the expression of all tested
genes (NLRP-1, NLRP-3, NLRC4/NALP4, AIM2, IL-1β,
IL-18, ASC, and TNF-α) was increased in inflamed liver
at all time points during ongoing insult (i.e. fibrogenesis)
suggesting that the expression of these genes is not only
necessary for disease initiation but also for progression
(Figure 3A). A detailed statistical analysis using the
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Figure 2 Expression of inflammasome components in rat cirrhotic fat storing cell line CFSC-2G subjected to LPS stimulation. CFSC-2G
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http://www.journal-inflammation.com/content/9/1/49Kruskal-Wallis test for nonparametric multiple compari-
son revealed that the observed increased expression of
NLRP-3, NLRP-1 and AIM2 reached statistical signifi-
cant values (Figures 3B, 3C, 3D).
mRNA expression of inflammasomes during experimental
liver insult induced by single or repeated application
of CCl4
We next tested the expression of various genes of the
inflammasome machinery in mice 48 hrs after CCl4injection. Compared to mice that received oil, the single
administration of CCl4 resulted in significant increased
expression of ASC, TNF-α, NLRP-1, NLRP-3, NLRC4/
NALP4 and AIM2 (Figure 4A, see Additional file 1 for
statistics) demonstrating that the single application of
CCl4 is already suitable to induce a strong inflammatory
reaction in liver. Under these conditions, we also observed
an elevated expression of CCL2/MCP-1 (Figure 4B) that is
known to be necessary for recruitment of monocytes,
memory T cells, and dendritic cells to sites of tissue injury,
control 2d 1w 2w 
NLRP-1
re
l. 
m
R
N
A
 e
xp
re
ss
io
n
BDL
0
1
2
3
4
5
6NLRP-3
re
l. 
m
R
N
A
 e
xp
re
ss
io
n
BDL
control 2d 1w 2w
0
1
2
3
4
5
6
control 2d 1w 2w
AIM2
re
l. 
m
R
N
A
 e
xp
re
ss
io
n
BDL
0
1
2
3
4
B C D
control 2 days BDL 7 days BDL 14 days BDL
0
1
2
3
4
5
6
7
NLRP-1 NLRP-3 NLRC4 AIM2 IL-1 IL-18 ASC TNF-
re
l. 
m
R
N
A
 e
xp
re
ss
io
n
A
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http://www.journal-inflammation.com/content/9/1/49infection, and inflammation [32,33]. When we analyzed
expression of NLRP-3 and NLRP-1 and AIM2 in livers
of animals that were subjected to prolonged treatment
with CCl4 for 1, 2, 4, 8 and 12 weeks, we noticed that
the initial high expression of all three genes were some-
what blunted at later time points and showed a some-
what undulated expression kinetics (Figure 4C).
Protein expression of inflammasomes during
experimental liver insult
To test if the observed mRNA expression kinetics of the
different inflammasomes after administration of CCl4 or
BDL surgery was also reflected at the protein level, we
performed immunohistochemistry for NALP3, NALP1,
AIM2, and NLRC4/NALP4 (Figures 5 and 6). In liver
sections that were prepared from animals that received
either BDL for 5 days, 2 weeks, and 4 weeks or sub-
jected to CCl4 for 1 week, 2 weeks or 4 weeks, we
found that hepatocytes stained weakly positive for
NLRP-3 (Figure 5A). In addition, another cell population
that was most likely KC stained strongly positive for
NLRP-3. In contrast, NLRP-3 was virtually absent in liversections taken from untreated controls. Similar results
were found for NALP1 (Figure 5B), AIM2 (Figure 6A),
and NLRC4/NALP4 (Figure 6B) suggesting that there
is (i) either an intensive influx of cells into liver with
capacity to express these proteins, (ii) an increased ex-
pression of inflammasome proteins in liver residential
cells (e.g. KC), or (iii) both cellular influx and enhanced
expression by hepatic cell subpopulations. By FACS-
based analysis of hepatic leukocyte isolates, we were
able to demonstrate that in both models (i.e. BDL,
CCl4) significant quantities of leukocytes infiltrated
the liver (Figure 7A). While the quantities of monocytes/
granulocytes (Figure 7B) were higher in the CCl4 model,
livers of BDL animals showed a marked increase of
macrophages (Figure 7C), while the number of neutro-
phils was higher in both models compared to untreated
control livers (Figure 7D).
Expression of inflammasomes and signaling cascades
activated during acute inflammatory stimuli
All these previous findings described above demonstrate
that various stimuli that induce liver damage are in
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Figure 4 Expression of inflammasome components in rat livers after application of CCl4. (A) Sprague Dawley rats received one single
application of CCl4 or oil. 48 hrs later RNA was prepared and analyzed for expression of IL-1α, IL-1β, IL-6, IL-10, IL-18, IFN-γ, ASC, TNF-α, NLRP-1,
NLRP-3, NLRC-4 and AIM2 by qRT-PCR. Details on primer combinations are given in Table 1. (B) The same set of RNAs from (A) was analyzed for
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http://www.journal-inflammation.com/content/9/1/49principle suitable to transcriptional activate the different
inflammasome branches simultaneously suggesting that
the subsequent molecular pathways regulated by these
pathways are highly complex especially at later time
points when secondary effects come along. Therefore,
we decided to exemplary analyze NLRP-3 expression
during the acute phase response. This reaction occurs
soon after setting of inflammatory stimuli and represents
a complex series of reactions resulting in the production
of inflammation-associated cytokines and diverse acute
phase proteins. For induction we either used the applica-
tion of LPS or Concanavalin A (Con A) for 6 hrs (LPS)
or 8 hrs (Con A). When we analyzed the expression of
NLRP-3 in liver protein extracts from animals that
received LPS, we found that the endotoxin induced ex-
pression of NLRP-3 at the protein level (Figure 8A). The
LPS injection further resulted in a significant induction
of the acute phase protein Lipocalin 2 (LCN2) andcorrelated well with the phosphorylation of the Signal
Transducers and Activators of Transcription-1 (STAT1)
that is involved in mediating the acute phase response
via transcriptional activation of cytokine inducible genes.
In line with this activation, we found that the LPS injec-
tion resulted in a significant phosphorylation of the
JNK-MAPK and NF-κB/p65 and an increased expression
of caspase-3. Significant phosphorylation of STAT-3 was
already observed at 2 hrs after LPS injection (not shown)
confirming well established findings that both STAT-1
and STAT-3 have critical roles in the control of systemic
inflammation and acute phase response [34,35]. The in-
duction of the acute phase response was further con-
firmed by quantitative analysis of various cytokine
mRNA expression measuring after 2 and 6 hrs after ap-
plication of LPS (Additional file 6: Figure S5A) and
increased expression of CCL2/MCP-1 (Additional file 6:
Figure S5B).
control 1 w CCl4 4 w CCl42 w CCl4
NLRP-3
(200X)
A
5 d BDLRabbit IgG 4 w BDL2 w  BDL
control 1 w CCl4 4 w CCl42 w CCl4
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Figure 5 Hepatic expression of NLRP-3 and NLRP-1 in rats after administration of CCl4 or BDL surgery. Liver specimen from animals that
received CCl4 or underwent BDL for indicated time points were stained with antibodies specific for NLRP-3 (A) or NLRP-1 (B). Section from
control animals and a stain with an unspecific rabbit IgG served as controls in this analysis.
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http://www.journal-inflammation.com/content/9/1/49In the other acute model (i.e. Con A), we again found
a strong upregulation of NLRP-3 that correlated well
with increased expression of LCN2, caspase-3 and ele-
vated phosphorylation of JNK and STAT-1 (Figure 8B).
In this model, the increase of NLRP-3 expression seems
to be the result of an increased transcriptional activation
of the Nlrp-3 gene (Figure 8C) and correlated well with
the expression of IL-1β and TNF-α that are indicative
for the acute phase response that is triggered by the LPS
stimulus (Figure 8D). Interestingly, the expression of
NLRC4/NALP4 and AIM2 was reduced after application
of Con A, while NLRP-1 gene expression was unaffected.Induction of inflammasome expression in primary
cultured hepatocytes and KC
In the initial analysis, we found that the expression of
inflammasomes in primary cultured hepatocytes is rather
low or even not detectable (cf. Figure 1). However, we
noticed in vivo that hepatocytes stained positive for NLRP-
3 when animals were subjected to BDL (cf. Figure 3E) sug-
gesting that hepatocytes should in principal be also able to
respond to inflammatory stimuli with expression of NLRP-
3 and other inflammasome-associated proteins. To testthis in more detail, we serum-starved primary isolated
murine hepatocytes to avoid influences of serum factors
and stimulated them with different concentration of
LPS for various time intervals and measured the ex-
pression of respective genes (Figure 9).
While the expression of NLRP-1 (Figure 9A), NLRC4/
NALP4 (Figure 9C), AIM2 (Figure 9D), and ASC
(Figure 9G) was nearly unaffected 30 min after stimula-
tion with 50-400 ng LPS/ml medium, the expression of
all four genes were more or less suppressed at later time
points. In contrast, the LPS challenge resulted in a drastic
upregulation of NLRP-3 expression (up to 100 fold two
hours after stimulation) at all concentrations tested
(Figure 9B). This expression pattern correlated well
with the expression of IL-1β (Figure 9E) and TNF-α
(Figure 9H). The analysis further revealed that the
mRNA quantity of caspase-1 that represents the major
protease necessary to activate the inflammasome ma-
chinery is also highest at 2 hrs, while the expression of
IL-18 in hepatocytes is unaffected after LPS challenge.
In this scenario it is most likely that liver residential
KC are the major source of IL-1β and TNF-α because it
is generally assumed and confirmed by our analysis
(Additional file 7: Figure S6) that primary isolated KC
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Figure 6 Hepatic expression of AIM2 and NALP4/NLRC4 in rats after administration of CCl4 or BDL surgery. Liver specimen from animals
that received CCl4 or underwent BDL for indicated time points were stained with antibodies specific for AIM2 (A) or NALP4/NLRC4 (B). Section
from control animals and a stain with an unspecific rabbit IgG served as controls in this analysis.
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http://www.journal-inflammation.com/content/9/1/49have a high capacity to express these pro-inflammatory
cytokines after LPS stimulation.
Discussion
There is no doubt that the understanding of inflamma-
some regulation and function will potentially offer great
opportunities to interfere with the process of inflamma-
tion, fibrogenesis and tumorigenesis. Irrespectively of
the inflammatory stimuli analyzed, the activation of the
inflammasome machinery is a well orchestrated process in
which pattern recognitions receptors recognize distinct
danger signals and in turn activate signaling pathways thatsubsequently initiate the inflammatory response resulting
in activation of different pathways such as NF-κB and
MAPK and culminating in transcriptional activation of a
large number of different inflammation-associated genes.
It is superfluous to mention and confirmed in our study
that this regulatory network is highly complex and that
the individual inflammasome protein complexes might
be simultaneously expressed and activated in the same
cell type at the same time in the inflamed tissue. Recent
studies have characterized and classified distinct molecu-
lar agents and pathways for several sensor proteins and
have identified a multitude of inflammatory ligands of
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Figure 9 Expression of inflammasomes in primary murine hepatocytes after stimulation with LPS. Primary hepatocytes in culture were
stimulated one day after isolation with 50, 100, 200 and 400 ng/ml LPS or left untreated. After indicated times (30 min, 1 h, 2 hrs, 4 hrs) RNA was
isolated from respective cells and tested for expression of NLRP-1 (A), NLRP-3 (B), NLRC-4 (C), AIM2 (D), IL-1β (E), IL-18 (F), ASC (G), and TNF-α (H)
by qRT-PCR. For detailed statistical analysis of this set of experiments see Additional file 1.
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http://www.journal-inflammation.com/content/9/1/49both endogenous and exogenous origin that drive inflam-
masome activities in healthy and diseased organs [5].
However, there is only limited knowledge of inflamma-
some regulation and function in healthy liver and various
liver diseases.
To allow quantification of mRNAs of genes that are
directly linked to the activity of the inflammasomes, we
have established qRT-PCR assays for mRNA quantifica-
tion of NLRP-3, NLRP-1, NLRC4/NALP4, AIM2, IL-1β,
IL-18, ASC, TNF-α, IL-6, IL-10 in mice and rat
(Additional file 2: Figure S1, Additional file 3: Figure S2).
We have shown that the expression of NLRP-1,
NLRP-3 and AIM2 in cultured primary cell population
is mainly restricted to KC, LSEC and pMF, while the
expression in HSC is only low and virtually absent in
primary cultured hepatocytes (Figure 1). However, the
challenge with LPS demonstrates that the expression of
respective genes involved in formation of inflamma-
somes can be induced to high levels in HSC/MFB
(Figure 2) and hepatocytes (Figure 6) suggesting that
all liver cell types tested are in principal able to mediate
inflammasome activities. Interestingly, NLRP-3, NLRP-1
and NLRC4/NALP4 are inducible in CFSC-2G in re-
sponse to LPS stimulation (Figure 2) demonstrating thatthe different inflammasome branches can be simultan-
eously activated at the same time in this cell entity.
However, during activation there seems to be a clear
sequential order because NLRP-3 expression was found
to be highest already one hour after LPS challenge,
while the elevated expression of NLRP-1 and NLRC4/
NALP4 followed one hour later.
During experimental liver insult induced by ligature of
the common bile duct (BDL), the expression of all four
core inflammasomes (i.e. NLRP-1, NLRP-3, NLRC4/
NALP4, and AIM2) were simultaneously activated at the
mRNA (Figures 3) and protein level (Figures 5 and 6).
Also the single or repeatedly application of CCl4 resulted
in a simultaneous increase of all four inflammasomes in
liver (Figure 4, Figures 5 and 6) suggesting that inflam-
matory stimuli induce a highly complex network of bio-
logical responses in residential and infiltrating cells in
which all inflammatory branches are integrated.
When mice were injected with LPS, the expression of
NLRP-3 was induced at both mRNA and protein levels
(Figure 5A) confirming previous reports [16]. LPS is a
prototypical ligand for the Toll like receptor 4 (TLR4)
that upon activation induces the production of pro-
inflammatory cytokines through activation of the NF-κB
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http://www.journal-inflammation.com/content/9/1/49pathway [36,37]. In addition, we observed a strong induc-
tion/activation (i. e. phosphorylation) of other genes in
that disease model which are involved in inflammatory
reactions and recovery from endotoxic shock including
LCN2, caspase-3, NF-κB, JNK, pSTAT1, and STAT3
[35,38]. A comparable activation pattern of all these
genes was observed when normal liver was challenged
with Con A (Figure 5B, 5C). Since Con A injection leads
to immune-mediated liver injury and release of several
cytokines (e.g. TNF-α, IFN-γ) triggering liver damage
[39], these findings suggest that irrespectively of the
stimuli triggering the inflammatory response, the subse-
quent changes within the liver end up in similar molecu-
lar alterations and correlate with the activation of the
NLRP-3 inflammasome.
Presently, we do not know if the induction/activation
of the diverse target genes and pathways occur in an
orchestrated way with NLRP-3 or if the activation of
these genes is mandatory to stimulate NLRP-3 expression.
However, based on our experimentation, it is reasonable
to speculate that the expression of inflammasome compo-
nents is directly linked to the activation of NF-κB. It is
known that under the condition of BDL, rats have an
overall constitutive activation of NF-κB in the liver [40].
Also carbon tetrachloride exposure in mice leads to acti-
vation of NF-κB [41]. Likewise, the application of the
lectin Con A and endotoxin LPS induces activation and
nuclear translocation of NF-κB [36,42]. Therefore, it will
be interesting to test if the administration of inhibitors
of canonical or non-canonical NF-κB signaling such as
the thiol-reactive quinol and putative thioredoxin inhibi-
tor PMX464 or the lack of factors necessary to activate/
phosphorylate NF-κB is suitable to interfere or blunt
expression of inflammasome genes.
The finding that purified hepatocytes alone do not
express inflammasome components (Figure 1) but induce
their transcription after appropriate challenge with in-
flammatory stimuli such as LPS (Figure 6) demonstrate
that the presence of immune cells per se is not necessary
to mediate respective responses in vitro. However, it will
be essential to analyze in vivo in more detail if the initi-
ation of inflammasome activity in inflamed liver tissue is
mainly triggered by influx of neutrophils, monocytes and
other immune cells, is a capacity of liver residential cells
or is the outcome of both processes. Based on our find-
ings, we suggest that infiltrating cells as well as liver resi-
dential cells have capacity to induce inflammasome
expression after appropriate trigger within the liver. Most
likely, all primary hepatic cell entities are capable to in-
duce inflammasome expression and act in conjunction
with infiltrating cells that may vary in the different ex-
perimental settings.
The fact that the immortalized cirrhotic fat storing
cell line CFSC-2G induces the inflammasome machineryafter challenge with LPS (Figure 2) further demonstrates
that immortalization is not sufficient to blunt inflamma-
some activity.
Definitely, we are still at the beginning in understand-
ing the regulation of inflammasomes in different disease
models and far away to understand the functions of the
individual components. The fact that the expression of
the different inflammasome branches in liver become
simultaneously activated during hepatic inflammation
and their linkage to the activation of general molecular
transcriptions factors (e.g. NF-κB) further strengthens
the notion that there are several master key switches of
inflammasome activity. It will be interesting and challen-
ging to unravel these interactions and to identify specific
regulatory control points that might be suitable for
pharmacological intervention.Conclusions
In regard to liver NLRP-1, NLRP-3 and AIM2 are most
prominently expressed in Kupffer cells and liver sinusoidal
endothelial cells, moderately expressed in periportal myofi-
broblasts and hepatic stellate cells, and virtually absent in
primary cultured hepatocytes. In vitro, the challenge of cul-
tured hepatic stellate cells with lipopolysaccharides results
in a time- and concentration-dependent upregulation of
NLRP-1, NLRP-3 and NLRC4/NALP4, while hepatocytes
respond mainly with a strong transcriptional activation
of NLRP-3. Our data using different experimental ani-
mals of inflammatory liver insult further indicates that
the various inflammasome components contribute sim-
ultaneously to the outcome of inflammatory liver dis-
ease, irrespectively of the underlying inflammatory
stimuli. The fact that the stimulation of all inflamma-
some branches in the different disease models leads to
simultaneous activation of general molecular transcrip-
tions factors (e.g. NF-κB) further strengthens the no-
tion that there are several master key switches
regulating inflammasome activity.
Additional files
Additional file 1. Statistics to Figure 2. Expression of inflammasome
components in rat cirrhotic fat storing cell line CFSC-2G subjected to LPS
stimulation. Statistics to Figure 3: Expression of inflammasome
components in rat livers after bile duct ligation (BDL). Statistics to Figure
4: Expression of inflammasome components in rat livers after application
of CCl4. Statistics to Figure 5: Expression of inflammasomes in mice after
Con A injection. Statistics to Figure 6: Expression of inflammasomes in
primary murine hepatocytes after stimulation with LPS. Statistics to Suppl.
Figure 3: Induction of acute phase response in mice after LPS injection.
Additional file 2: Figure S1. Establishment of TaqMan tests for
expression analysis of individual inflammasome genes in rats. TaqMan
assays for rat NLRP-3 (A), NLRC-4 (B), AIM2 (C), IL-1β (D), IL-18 (E),
ASC (F), TNF-α (G), and rS6 (H) were established. Representative
melting curves for each gene are depicted. Amplification of respective
target gene sequences were performed under the same cycling
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http://www.journal-inflammation.com/content/9/1/49conditions using a melting temperature of 95°C and amplification/
extension temperatures of 60°C, respectively. The individual primer
combinations used in each test are depicted in Table 1.
Additional file 3: Figure S2. Establishment of TaqMan tests for
expression analysis of individual inflammasome genes in mouse. TaqMan
assays for murine NLRP-1b (A), NLRP-1c (B), NLRP-3 (C), NLRC-4 (D), AIM2
(E), IL-1β (F), IL-18 (G), ASC (H), TNF-α (I), IL-6 (J), IL-10 (K), IFN-γ (L) and
GAPDH (M) were established. Amplification of the different gene
sequences were essentially performed under the same cycling conditions
each using a melting temperature of 95°C and amplification/extension
temperatures of 60°C, respectively. Representative melting curves for
each gene are depicted. The individual primer combinations used in
each test are depicted in Table 1.
Additional file 4: Figure S3. Analysis of DNA fragmentation after
treatment with LPS. (A) TUNEL assay in CFSC-2G cells that were
stimulated in short (30 min) and long term (16 h) with 200 ng/ml LPS
kept their cellular integrity. The nuclei are counterstained with DAPI.
Additional file 5: Figure S4. Analysis of cell cytotoxicity after
treatment with LPS. (A) The standard curve for measurement of LDH
activity was established with a preparation of hog LDH. (B) The chosen
kit system allows to measure LDH activity in a wide range from 0.001
(Background), to 5,083 (high control). (C) Measurement of LDH in cellular
supernatants of CFSC-2G cells that were incubated with indicated
concentrations of LPS for indicated time intervals reveal only low cellular
toxicity of LPS.
Additional file 6: Figure S5. Induction of acute phase response in
mice after LPS injection. (A) Mice were subjected to LPS stimulation and
livers samples were taken after 2 and 6 hours. The expression of pro-
inflammatory, anti-inflammatory cytokines as well as indicated
inflammasome components was analyzed by qRT-PCR. (B) Expression
analysis of the monocyte chemotactic protein (MCP-1, CCL2) in livers
after LPS injection. For detailed statistical analysis of this set of
experiments see Additional file 1.
Additional file 7: Figure S6. Expression analysis of Kupffer cells after
stimulation with LPS. Primary KC were stimulated with indicated
concentration of LPS for 2 hrs and the expression of (A) NLRP-1, NLRC4/
NALP4, AIM2, IL-18, ASC and (B) NLRP-3, IL-1β and TNF-α determined by
quantitative RT-PCR. In this analysis, the target gene expression without
stimulation with LPS was set to 1.
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